J9394 Fulvestrant (Fresnius) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Fulvestrant (Fresnius)

Brand Name:

Fulvestrant (Fresnius)

Strength:

25mg

HCPCS:

J9394

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Estrogen Receptor Antagonist

Minor Drug Class:

Oral (Y/N):

No

FDA Approval Year:

2019

FDA Discontinuation Year:

CMS Effective Date:

Dec. 21, 2022

CMS Discontinuation Date:

Status:

In Use